Fri, December 7, 2018
Thu, December 6, 2018
Wed, December 5, 2018
Tue, December 4, 2018
Mon, December 3, 2018
Fri, November 30, 2018

Charles Duncan Upgraded (VNDA) to Buy and Held Target at $43 on, Dec 4th, 2018

Charles Duncan of Cantor Fitzgerald, Upgraded "Vanda Pharmaceuticals Inc." (VNDA) to Buy and Held Target at $43 on, Dec 4th, 2018.

Charles has made no other calls on VNDA in the last 4 months.



There are 3 other peers that have a rating on VNDA. Out of the 3 peers that are also analyzing VNDA, 0 agree with Charles's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Charles


  • Chris Howerton of "Jefferies" Initiated at Strong Buy and Held Target at $26 on, Thursday, November 8th, 2018
  • Joel Beatty of "Citigroup" Maintained at Strong Buy with Increased Target to $31 on, Tuesday, October 16th, 2018
  • Derek Archila of "Oppenheimer" Maintained at Buy with Increased Target to $29 on, Friday, September 21st, 2018